Percorso will commercialize Generation Biotech's bead-based haplotype- and region-specific extraction technology.
Promega will sell a combined offering of kinase profiling tools from the two firms.
The firms are working on infectious disease diagnostics using Protagen's UNIarray platform.
RainDance's Sequence Enrichment application enhances SeqWright's targeted resequencing and whole-genome sequencing capabilities for studying disease pathways, cancer, and other areas of research, SeqWright said.
The agreement formalizes a marketing partnership with GeneDiagnostics to sell the ColonSentry test in certain parts of China.
Starting next month, PGXL and Generation Health will provide pharmacogenetic testing and diagnostic services to patients through healthcare providers.
Under the deal, System Biosciences will convert many of DV Biologics' disease-specific cell types into induced pluripotent stem cell lines.
In clinical studies, the test demonstrated 97.1 percent positive agreement and 100 percent negative agreement with conventional methods of testing for MRSA, AdvanDx said.
1st Base will promote Protoemics International's proteomics services in Singapore, Malaysia, Indonesia, and Thailand.
The companies have integrated HTG's qBead technology for use on the Luminex xMAP multiplexing platform.
CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.
Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.
Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.
In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.